Gelsolin regulates proliferation, apoptosis and invasion in NK/T-cell lymphoma cells through the PI3K/Akt signaling pathway
Y. Guo, H. Zhang, X. Xing, L. Wang, J. Zhang, L. Yan, X. Zheng, M. Zhang
Abstract
The expression of gelsolin (GSN) is abnormal in many cancers, including extranodal nasal-type natural killer/T-cell lymphoma (NKTCL). However, the biological function of GSN and its mechanism in NKTCL remain unclear. We found GSN overexpression significantly suppressed cell proliferation, colony formationand invasion and promoted apoptosis of YTS cells. Moreover, the upregulation of GSN significantly decreased the protein levels of PI3K and p-AKT. Interestingly, blocking the PI3K/AKT signaling pathway significantly inhibited cell proliferation and invasion and promoted apoptosis of YTS cells. In conclusion, our findings indicate that GSN can suppress cell proliferation and invasion and promote apoptosis of YTS cells, which is likely to be mediated at least partially through inhibition of the PI3K/AKT signaling pathway.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Downregulation of NCL attenuates tumor formation and growth in cervical cancer by targeting the PI3K/AKT pathway
- Therapeutic blockade of Activin-A improves NK cell function and anti-tumor immunity
Jai Rautela, Laura F. Dagley, … Fernando Souza-Fonseca-Guimaraes·bioRxiv·Oct 29, 2018
- Antibody targeting of surface PSGL-1 glycoprotein leads to lymphoma apoptosis and tumorigenesis inhibition
João L. Pereira, Francisca Ferreira, Nuno R. dos Santos·Hematological OncologyPeer-reviewed·Feb 28, 2024
- FYN tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates anti-glioma immune responses
A. Comba, P. J. Dunn, … P. R. Lowenstein·bioRxiv·Dec 17, 2019
- nsGSLs on tumors impair anti-tumor immune responses by OT-I T cells in vitro and support tumor growth in vivo
Tamara Verkerk, Aimee Selten, … S. Marieke van Ham·bioRxiv·Oct 13, 2024
- Specific Inhibition of GSK-3β by Tideglusib: Potential Therapeutic Target for Neuroblastoma Cancer Stem Cells
H. F. Bahmad, R. M. Chalhoub, … W. Abou-Kheir·bioRxiv·Feb 18, 2020